4th Quarter - Report
SIGHTLINE ADVOCACY, LLC for AMGEN
Client
Income
$20,000
Expenses
—
What was lobbied
One issue area, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Issues related to drug pricing; H.R. 5526 - Biosimilar Red Tape Elimination Act
| Lobbyist | Covered position, as disclosed |
|---|---|
| TYLER STEPHENS | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.